Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Taku Kinoshita; Masahiro Shinoda; Yasuhiro Nishizaki; Katsuya Shiraki; Yuji Hirai; Yoshiko Kichikawa; Kenji Tsushima; Masaharu Shinkai; Naoyuki Komura; Kazuo Yoshida; Yasutoshi Kido; Hiroshi Kakeya; Naoto Uemura; Junichi Kadota

doi:10.1186/s12916-022-02695-5

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

BMC Med. 2022 Dec 8;20(1):478. doi: 10.1186/s12916-022-02695-5.

Authors

Taku Kinoshita^{1

2}, Masahiro Shinoda³, Yasuhiro Nishizaki⁴, Katsuya Shiraki⁵, Yuji Hirai⁶, Yoshiko Kichikawa⁷, Kenji Tsushima¹, Masaharu Shinkai³, Naoyuki Komura⁸, Kazuo Yoshida⁹, Yasutoshi Kido^{10

11

12}, Hiroshi Kakeya^{13

14}, Naoto Uemura¹⁵, Junichi Kadota^{16

17}

Affiliations

¹ Department of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
² Present Address: Respiratory Medicine, Chiba Rosai Hospital, Chiba, Japan.
³ Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo, Japan.
⁴ Tokai University Tokyo Hospital, Tokyo, Japan.
⁵ Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan.
⁶ Department of Infectious Diseases, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan.
⁷ Department of Respiratory Medicine, Mishuku Hospital, Tokyo, Japan.
⁸ Clinical Development Planning, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
⁹ Department of Statistical Analysis, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
¹⁰ Department of Parasitology and Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka City University, Osaka, Japan.
¹¹ Department of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
¹² Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
¹³ Department of Infection Control Science, Graduate School of Medicine, Osaka City University, Osaka, Japan.
¹⁴ Department of Infection Control Science, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
¹⁵ Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita-ken, 879-5593, Japan. uemura@oita-u.ac.jp.
¹⁶ Department of Respiratory Medicine and Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan.
¹⁷ Nagasaki Harbor Medical Center, Nagasaki, Japan.

No abstract available

Publication types

Published Erratum